ADPT logo

ADPT Selling, General & Administrative Expenses

Annual SG&A:

$157.56M-$14.95M(-8.66%)
December 31, 2024

Summary

  • As of today (October 3, 2025), ADPT annual SG&A is $157.56 million, with the most recent change of -$14.95 million (-8.66%) on December 31, 2024.
  • During the last 3 years, ADPT annual SG&A has fallen by -$12.40 million (-7.30%).
  • ADPT annual SG&A is now -14.43% below its all-time high of $184.13 million, reached on December 31, 2022.

Performance

ADPT SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

Quarterly SG&A:

$41.36M+$913.00K(+2.26%)
June 30, 2025

Summary

  • As of today (October 3, 2025), ADPT quarterly SG&A is $41.36 million, with the most recent change of +$913.00 thousand (+2.26%) on June 30, 2025.
  • Over the past year, ADPT quarterly SG&A has increased by +$3.15 million (+8.24%).
  • ADPT quarterly SG&A is now -17.67% below its all-time high of $50.24 million, reached on March 31, 2022.

Performance

ADPT Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

TTM SG&A:

-$5.27B-$121.23M(-2.36%)
June 30, 2025

Summary

  • As of today (October 3, 2025), ADPT TTM SG&A is -$5.27 billion, with the most recent change of -$121.23 million (-2.36%) on June 30, 2025.
  • Over the past year, ADPT TTM SG&A has dropped by -$5.43 billion (-3324.81%).
  • ADPT TTM SG&A is now -1679.92% below its all-time high of -$295.91 million.

Performance

ADPT TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

ADPT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-8.7%+8.2%-3324.8%
3Y3 Years-7.3%-9.1%-2859.5%
5Y5 Years+129.1%+55.7%-5378.5%

ADPT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-14.4%at low-10.4%+9.4%-63.9%at low
5Y5-Year-14.4%+129.1%-17.7%+55.8%-217.4%at low
All-TimeAll-Time-14.4%+381.6%-17.7%+331.3%-1679.9%at low

ADPT Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$41.36M(+2.3%)
$159.25M(+2.0%)
Mar 2025
-
$40.45M(+2.1%)
$156.09M(-0.9%)
Dec 2024
$157.56M(-8.7%)
$39.63M(+4.8%)
$157.56M(-1.9%)
Sep 2024
-
$37.81M(-1.0%)
$160.57M(-1.7%)
Jun 2024
-
$38.21M(-8.8%)
$163.32M(-4.7%)
Mar 2024
-
$41.92M(-1.7%)
$171.29M(-0.7%)
Dec 2023
$172.51M(-6.3%)
$42.63M(+5.1%)
$172.51M(-2.0%)
Sep 2023
-
$40.57M(-12.1%)
$176.03M(-1.0%)
Jun 2023
-
$46.17M(+7.0%)
$177.72M(+0.4%)
Mar 2023
-
$43.14M(-6.5%)
$177.03M(-3.9%)
Dec 2022
$184.13M(+8.3%)
$46.14M(+9.2%)
$184.13M(-2.1%)
Sep 2022
-
$42.27M(-7.1%)
$188.03M(-1.5%)
Jun 2022
-
$45.48M(-9.5%)
$190.86M(+3.4%)
Mar 2022
-
$50.24M(+0.4%)
$184.66M(+8.6%)
DateAnnualQuarterlyTTM
Dec 2021
$169.97M(+53.3%)
$50.04M(+11.0%)
$169.97M(+11.9%)
Sep 2021
-
$45.10M(+14.8%)
$151.87M(+13.9%)
Jun 2021
-
$39.28M(+10.5%)
$133.32M(+10.5%)
Mar 2021
-
$35.54M(+11.3%)
$120.61M(+8.8%)
Dec 2020
$110.89M(+61.2%)
$31.94M(+20.3%)
$110.89M(+11.1%)
Sep 2020
-
$26.55M(-0.1%)
$99.78M(+9.9%)
Jun 2020
-
$26.57M(+2.9%)
$90.80M(+13.8%)
Mar 2020
-
$25.83M(+24.0%)
$79.79M(+16.0%)
Dec 2019
$68.78M(+53.2%)
$20.83M(+18.5%)
$68.78M(+10.0%)
Sep 2019
-
$17.58M(+13.0%)
$62.52M(+39.1%)
Jun 2019
-
$15.56M(+5.0%)
$44.95M(+52.9%)
Mar 2019
-
$14.82M(+1.8%)
$29.39M(+21.7%)
Dec 2018
$44.90M(+37.2%)
$14.57M(+51.9%)
$24.16M(+151.9%)
Mar 2018
-
$9.59M
$9.59M
Dec 2017
$32.71M
-
-

FAQ

  • What is Adaptive Biotechnologies Corporation annual SG&A?
  • What is the all-time high annual SG&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation annual SG&A year-on-year change?
  • What is Adaptive Biotechnologies Corporation quarterly SG&A?
  • What is the all-time high quarterly SG&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation quarterly SG&A year-on-year change?
  • What is Adaptive Biotechnologies Corporation TTM SG&A?
  • What is the all-time high TTM SG&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation TTM SG&A year-on-year change?

What is Adaptive Biotechnologies Corporation annual SG&A?

The current annual SG&A of ADPT is $157.56M

What is the all-time high annual SG&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high annual SG&A is $184.13M

What is Adaptive Biotechnologies Corporation annual SG&A year-on-year change?

Over the past year, ADPT annual SG&A has changed by -$14.95M (-8.66%)

What is Adaptive Biotechnologies Corporation quarterly SG&A?

The current quarterly SG&A of ADPT is $41.36M

What is the all-time high quarterly SG&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high quarterly SG&A is $50.24M

What is Adaptive Biotechnologies Corporation quarterly SG&A year-on-year change?

Over the past year, ADPT quarterly SG&A has changed by +$3.15M (+8.24%)

What is Adaptive Biotechnologies Corporation TTM SG&A?

The current TTM SG&A of ADPT is -$5.27B

What is the all-time high TTM SG&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high TTM SG&A is -$295.91M

What is Adaptive Biotechnologies Corporation TTM SG&A year-on-year change?

Over the past year, ADPT TTM SG&A has changed by -$5.43B (-3324.81%)
On this page